Advertisement Active Biotech names new CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Active Biotech names new CEO

Active Biotech has named Tomas Leanderson to become the new president & CEO. Tomas Leanderson has been the CSO for Active Biotech since 1999.

Previously the company announced that Sven Andreasson has notified the company of his wish to resign from the position as president & CEO.

Sven Andreasson has been the company’s CEO since 1999 and under his leadership Active Biotech is said to have been transformed from a combined vaccine and research company into a company focused on development of novel pharmaceuticals for treatment of cancer and autoimmune diseases.
Sven Andreasson will remain as CEO until September 1, 2008.